Hematology | Oncology


The Clinical Trials Office of the Cancer Research Center coordinates our participation in several national cancer cooperative trials directed not only at new therapies but also at prevention, education and screening for early detection. A key component is our active participation in the Southwest Oncology Group (SWOG), a national clinical trials cooperative established with National Cancer Institute (NCI) funding. We are the only full-member institution in New England. We are also members of NSBBP (National Surgical Breast and Bowel program.) Participation in SWOG and NSBBP gives us access to many investigational drugs and protocols sponsored by the NCI that would be unavailable otherwise. In addition, we are the principal investigators for a series of clinical trials at Boston Medical Center.

Basic research
We are examining the genetics of cancer cells, their ability to escape immune response and their resistance to the process of differentiation. Activators of programmed cell death are in laboratory development and early clinical trials at Boston Medical Center. This special relationship between the laboratory and the clinic provide unique opportunities to explore and develop new therapies.